Diabetic Nephropathies

"Diabetic Nephropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Descriptor ID	D003928
MeSH Number(s)	C12.777.419.192 C13.351.968.419.192 C19.246.099.875
Concept/Terms	Diabetic Nephropathies Diabetic Nephropathies Nephropathies, Diabetic Nephropathy, Diabetic Diabetic Nephropathy Diabetic Kidney Disease Diabetic Kidney Diseases Kidney Disease, Diabetic Kidney Diseases, Diabetic Diabetic Glomerulosclerosis Diabetic Glomerulosclerosis Kimmelstiel-Wilson Syndrome Kimmelstiel Wilson Syndrome Syndrome, Kimmelstiel-Wilson Kimmelstiel-Wilson Disease Kimmelstiel Wilson Disease Nodular Glomerulosclerosis Glomerulosclerosis, Nodular Glomerulosclerosis, Diabetic Intracapillary Glomerulosclerosis

Below are MeSH descriptors whose meaning is more general than "Diabetic Nephropathies".

Diseases [C]
Male Urogenital Diseases [C12]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Diabetic Nephropathies [C12.777.419.192]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Diabetic Nephropathies [C13.351.968.419.192]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Nephropathies [C19.246.099.875]

Below are MeSH descriptors whose meaning is more specific than "Diabetic Nephropathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Nephropathies" by people in this website by year, and whether "Diabetic Nephropathies" was a major or minor topic of these publications.

Bar chart showing 74 publications over 23 distinct years, with a maximum of 8 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1995	0	1	1
1997	0	1	1
1998	2	1	3
2002	3	0	3
2003	4	0	4
2004	1	1	2
2005	5	0	5
2006	1	2	3
2007	3	2	5
2008	3	2	5
2009	2	0	2
2010	1	0	1
2011	2	1	3
2012	1	4	5
2013	6	2	8
2014	3	0	3
2015	4	1	5
2016	1	1	2
2017	4	0	4
2018	2	0	2
2019	4	1	5
2020	1	0	1

Below are the most recent publications written about "Diabetic Nephropathies" by people in Profiles.

Pavlov TS, Palygin O, Isaeva E, Levchenko V, Khedr S, Blass G, Ilatovskaya DV, Cowley AW, Staruschenko A. NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease. FASEB J. 2020 10; 34(10):13396-13408.

View in: PubMed
Palygin O, Spires D, Levchenko V, Bohovyk R, Fedoriuk M, Klemens CA, Sykes O, Bukowy JD, Cowley AW, Lazar J, Ilatovskaya DV, Staruschenko A. Progression of diabetic kidney disease in T2DN rats. Am J Physiol Renal Physiol. 2019 12 01; 317(6):F1450-F1461.

View in: PubMed
Hunt KJ, Jenkins AJ, Fu D, Stevens D, Ma JX, Klein RL, Azar M, Zhang SX, Lopes-Virella MF, Lyons TJ. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019 10; 33(10):107410.

View in: PubMed
Mendez CE, Walker RJ, Eiler CR, Mishriky BM, Egede LE. Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. Postgrad Med. 2019 Aug; 131(6):376-382.

View in: PubMed
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. 2019 07 13; 394(10193):131-138.

View in: PubMed
Arif E, Nihalani D. Beta2-adrenergic receptor in kidney biology: A current prospective. Nephrology (Carlton). 2019 May; 24(5):497-503.

View in: PubMed
Spires D, Ilatovskaya DV, Levchenko V, North PE, Geurts AM, Palygin O, Staruschenko A. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Am J Physiol Renal Physiol. 2018 10 01; 315(4):F1091-F1097.

View in: PubMed
Ilatovskaya DV, Blass G, Palygin O, Levchenko V, Pavlov TS, Grzybowski MN, Winsor K, Shuyskiy LS, Geurts AM, Cowley AW, Birnbaumer L, Staruschenko A. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease. J Am Soc Nephrol. 2018 07; 29(7):1917-1927.

View in: PubMed
Obadan NO, Walker RJ, Egede LE. Independent correlates of chronic kidney disease awareness among adults with type 2 diabetes. J Diabetes Complications. 2017 Jun; 31(6):988-991.

View in: PubMed
Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. 2017 Jan 17; 356:i6505.

View in: PubMed

People

Explore

Similar Concepts

Top Journals